BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 15, 2009
View Archived Issues
Generics describes tegaserod salts for the treatment of irritable bowel syndrome
Read More
Eisai reports results of first quarter 2009, ended June 30
Read More
BHR to commence phase III study of progesterone in traumatic brain injury
Read More
Gefitinib prolongs progression-free survival in EGFR-positive pulmonary adenocarcinoma patients
Read More
Novel oncolytic PI3-kinase inhibitors claimed by Genentech and Roche
Read More
TpoR agonists identified by Shanghai Hengrui for the treatment of thrombocytopenia
Read More
NephroGenex completes enrollment in Pyridorin trial
Read More
FDA Advisory Committee recommends approval for Gardasil in boys and men
Read More
Anadys commences dosing in phase II ANA-598 trial in hepatitis C
Read More
Cempra initiates phase II/III trial in acute bacterial skin structure infections
Read More
FDA clears Vermillion's OVA1 test to determine risk for ovarian cancer
Read More
Pluristem Therapeutics commences enrollment in phase I PLX-PAD trial
Read More
Halozyme Therapeutics initiates phase I clinical trial with Roche biologic
Read More
Phase III aflibercept trial in metastatic pancreatic cancer discontinued
Read More
Millennium initiates phase II trial for TAK-700 in prostate cancer
Read More
Alexza reports preliminary results from phase IIb AZ-104 trial in migraine
Read More
ADX-10059 may have potential for treating levodopa-induced dyskinesia
Read More
GSK-3beta inhibitors in early development at Mitsubishi Tanabe Pharma and sanofi-aventis
Read More
Oxagen discloses CRTH2 receptor antagonists for the treatment of allergic diseases
Read More
Activity of novel antifungal FG-3622 described at ICAAC
Read More
FDA removes clinical hold on Heplisav phase III hepatitis B vaccine
Read More
S-equol efficacious in rat osteoporosis model
Read More
FDA and EMEA grant orphan drug status for trabedersen in pancreatic carcinoma
Read More
Cymbalta-treated patients with chronic low back pain maintain pain reduction
Read More
siRNA-mediated inhibition of Junin virus replication reported by Argentine scientists
Read More